Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Hao Lei(Xi'an Jiaotong University), Minhang Xin(Xi'an Jiaotong University), Shuai Mao(Xi'an Jiaotong University), Huanrong Bai(Xi'an Jiaotong University), Shu Fan(Xi'an Jiaotong University), San‐Qi Zhang(Xi'an Jiaotong University), Hongyi Zhao(Xi'an Jiaotong University)
Cited by 26
Related Papers
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y
|European Journal of Medicinal Chemistry|2019|192
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
|European Journal of Medicinal Chemistry|2018|168
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
|European Journal of Medicinal Chemistry|2020|120
Strategies to target the Hedgehog signaling pathway for cancer therapy
|Medicinal Research Reviews|2018|108